wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37604501-8C0840BD-5A05-41AD-B12B-E373A6AED208
Q37604501-8C0840BD-5A05-41AD-B12B-E373A6AED208
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-8C0840BD-5A05-41AD-B12B-E373A6AED208
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
P1476
Q37604501-8C0840BD-5A05-41AD-B12B-E373A6AED208
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-8C0840BD-5A05-41AD-B12B-E373A6AED208
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8b686291756c9ab815303fcfa1158383bf83d0b0
P1476
Baricitinib in patients with i
......
sults from the RA-BUILD study.
@en